Kumamoto, Japan

Yohsuke Maeda

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yohsuke Maeda. Retrieved from https://idiyas.com/inventor/yohsuke-maeda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yohsuke Maeda

Introduction

Yohsuke Maeda is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiretroviral agents. His work has the potential to impact the treatment of retroviral infections and related conditions.

Latest Patents

Yohsuke Maeda holds a patent for an antiretroviral agent, which includes a method of use and preparation. The patent focuses on pyrroline compounds that are effective in treating retroviral infections and lymphadenopathy. This innovation represents a crucial advancement in the fight against viral diseases.

Career Highlights

Maeda is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in research and development. His expertise in pharmaceutical sciences has led to breakthroughs that enhance treatment options for patients suffering from viral infections.

Collaborations

Throughout his career, Maeda has collaborated with esteemed colleagues such as Kiyoshi Takatsuki and Toshio Hattori. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yohsuke Maeda's contributions to the field of pharmaceuticals, particularly through his patent for an antiretroviral agent, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…